Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
3.
Neurology ; 69(14): 1460-5, 2007 Oct 02.
Article in English | MEDLINE | ID: mdl-17909159

ABSTRACT

OBJECTIVE: To examine the relation between the results of cardiac (123)I-meta-iodobenzylguanidine (MIBG) scintigraphy and cardiovascular autonomic function in Lewy body disease (LBD). METHODS: The subjects were 66 patients with LBD, 44 of whom had Parkinson disease (PD), 10 PD with dementia (PDD), and 12 dementia with Lewy bodies (DLB); 20 age-matched healthy subjects were studied as controls. Cardiovascular autonomic function was evaluated on the basis of cardiac (123)I-MIBG uptake, cardiovascular autonomic response on the Valsalva maneuver (VM), and systolic blood pressure (SBP) response on head-up tilt table (HUT) testing. RESULTS: Patients with LBD had reduced cardiac (123)I-MIBG uptake, cardiovascular autonomic response on the VM, and SBP response on HUT testing as compared with controls. Cardiac (123)I-MIBG uptake and cardiovascular autonomic function in PDD and DLB were severely impaired as compared with those in PD. Cardiac (123)I-MIBG uptake in LDB was not significantly related to vasomotor sympathetic function, baroreceptor reflex gain, cardiac parasympathetic function, or the changes in SBP on HUT testing. Cardiac (123)I-MIBG uptake was, however, significantly related to the blood pressure overshoot in phase IV of the VM. CONCLUSION: Cardiac (123)I-meta-iodobenzylguanidine uptake clinically reflects cardiac sympathetic dysfunction in Lewy body disease.


Subject(s)
Autonomic Nervous System Diseases/diagnostic imaging , Autonomic Nervous System Diseases/physiopathology , Heart/physiopathology , Lewy Body Disease/physiopathology , 3-Iodobenzylguanidine/pharmacokinetics , Aged , Aged, 80 and over , Autonomic Nervous System Diseases/etiology , Blood Pressure , Cardiac Output , Female , Heart/innervation , Heart Rate/drug effects , Humans , Lewy Body Disease/complications , Male , Middle Aged , Myocardium/metabolism , Predictive Value of Tests , Radionuclide Imaging , Sympathetic Fibers, Postganglionic/physiopathology , Valsalva Maneuver
4.
J Neurol Neurosurg Psychiatry ; 77(12): 1313-7, 2006 Dec.
Article in English | MEDLINE | ID: mdl-16891383

ABSTRACT

OBJECTIVE: To study the ability of patients with semantic dementia to understand actions, in order to examine the contribution of semantic memory to action comprehension. METHODS: The ability to comprehend symbolic and instrumental actions was assessed in 6 patients with semantic dementia and 10 healthy controls. The patients were also given the imitation test of meaningful and meaningless actions. RESULTS: In all patients with semantic dementia, comprehension of both symbolic and instrumental actions was defective. The comprehension of symbolic actions was more impaired than that of instrumental actions. Their ability to imitate other's actions was well preserved. CONCLUSION: This study showed that comprehension of action was impaired in semantic dementia, suggesting that semantic memory has an important role in comprehension of human action.


Subject(s)
Cognition , Dementia/psychology , Memory , Aged , Female , Humans , Male , Middle Aged , Symbolism
5.
Acta Neurol Scand ; 113(4): 221-7, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16542160

ABSTRACT

OBJECTIVES: To determine whether Parkinson's disease (PD) can be distinguished from multiple system atrophy (MSA) on the basis of the assessment of iodine-123 meta-iodobenzylguanidine (123I-MIBG) radioactivity in heart and cardiovascular autonomic function. PATIENTS AND METHODS: Seventeen patients with MSA, 39 with PD, and 25 healthy volunteers underwent 123I-MIBG scintigraphy and hemodynamic autonomic function tests using Valsalva maneuver (VM). Baroreceptor reflex sensitivity (BRS) was measured using the slope of the relation between RR interval and blood pressure during the fourth phase. RESULTS: 123I-MIBG radioactivity in heart of patients with PD was lower than that of control subjects and patients with MSA, but there was some overlap between PD and MSA. BRS in patients with PD who had a 123I-MIBG radioactivity similar to that in MSA was larger than that in patients with MSA, with no overlap in any patient. CONCLUSION: Assessment of BRS may be useful for differentiating between MSA and PD that had a 123I-MIBG radioactivity similar to MSA.


Subject(s)
Autonomic Nervous System/physiopathology , Cardiovascular System/innervation , Multiple System Atrophy/diagnostic imaging , Multiple System Atrophy/physiopathology , Parkinson Disease/diagnostic imaging , Parkinson Disease/physiopathology , 3-Iodobenzylguanidine , Aged , Autonomic Nervous System/diagnostic imaging , Baroreflex/physiology , Cardiovascular System/diagnostic imaging , Cardiovascular System/physiopathology , Case-Control Studies , Humans , Iodine Radioisotopes , Middle Aged , Radionuclide Imaging , Radiopharmaceuticals , Valsalva Maneuver
6.
Brain Dev ; 23(1): 50-3, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11226731

ABSTRACT

A prominent neuropathological change observed in a murine model of congenital toxoplasmosis is cerebral cortical hypoplasia. In the early embryonic life of toxoplasmosis mice, the number of apoptotic cell observed in cerebral cortex is increased, indicating that increased number of apoptotic cells might relate to the pathogenetic mechanism of the cortical hypoplasia. Immunohistochemical expression of apoptosis-related factors, Bcl-2 and Bax has been studied in fetal murine brains infected with toxoplasma and in controls. Paraffin sections of the fetal brains on embryonic day (ED) 10, 12, 14, 16 and 18 were applied for the immunostains of Bcl-2 and Bax. Totally, 47 experimental animals (ED10: n=8, ED12: n=6, ED14: n=12, ED16: n=6, ED18: n=15) and 48 control animals (ED10: n=6, ED12: n=8, ED14: n=9, ED16: n=9, ED18: n=16) were examined. Bcl-2 positive cells were detected on ED10, whereas Bax positive cells appeared on ED14. No difference of Bcl-2 and Bax expression between toxoplasmosis and control groups was detected, suggesting that there is no clear relation between Bax-induced apoptosis and cortical dysplasia in congenital toxoplasmosis.


Subject(s)
Apoptosis/physiology , Cerebral Cortex/abnormalities , Nervous System Malformations/parasitology , Proto-Oncogene Proteins/metabolism , Toxoplasmosis, Cerebral/metabolism , Toxoplasmosis, Congenital/metabolism , Animals , Body Patterning/physiology , Cerebral Cortex/pathology , Cerebral Cortex/physiopathology , Female , Fetus , Mice , Mice, Inbred C57BL , Nervous System Malformations/pathology , Nervous System Malformations/physiopathology , Neurons/metabolism , Neurons/pathology , Proto-Oncogene Proteins c-bcl-2/metabolism , Toxoplasma/pathogenicity , Toxoplasma/physiology , Toxoplasmosis, Animal/metabolism , Toxoplasmosis, Animal/pathology , Toxoplasmosis, Animal/physiopathology , Toxoplasmosis, Cerebral/pathology , Toxoplasmosis, Cerebral/physiopathology , Toxoplasmosis, Congenital/pathology , Toxoplasmosis, Congenital/physiopathology , bcl-2-Associated X Protein
7.
Intern Med ; 37(11): 945-9, 1998 Nov.
Article in English | MEDLINE | ID: mdl-9868957

ABSTRACT

A 32-year-old man who had had frequent gouty arthritis over the past 17 years, was admitted for acute renal failure. Acute renal failure was improved rapidly after medication was resumed and the patient was sufficiently hydrated. The hypoxanthine-guanine phosphoribosyltransferase (HPRT) activity in the patient had been reduced to about 30% of the normal control. Therefore we considered that this patient suffered from a partial deficiency of HPRT. A point mutation of HPRT gene 68G (guanine) to T (thymine) was detected. This is a mutation that has not been previously reported. Familial analysis indicated that his mother and sister were heterozygotes.


Subject(s)
Acute Kidney Injury/enzymology , Hypoxanthine Phosphoribosyltransferase/deficiency , Acute Kidney Injury/diagnosis , Adult , Allopurinol/therapeutic use , Arthritis, Gouty/complications , Arthritis, Gouty/diagnosis , Arthritis, Gouty/drug therapy , Arthritis, Gouty/enzymology , DNA/analysis , DNA Probes/chemistry , Diagnosis, Differential , Follow-Up Studies , Gout Suppressants/therapeutic use , Humans , Hypoxanthine Phosphoribosyltransferase/genetics , Male , Middle Aged , Nuclear Family , Point Mutation , Reverse Transcriptase Polymerase Chain Reaction
8.
No Shinkei Geka ; 19(3): 241-6, 1991 Mar.
Article in Japanese | MEDLINE | ID: mdl-2038413

ABSTRACT

In this study, we tried to examine the efficacy of a cytotoxic factor which is induced by periodic, repeated local administration of OK-432 into the tumor cavity of malignant glioma patients. OK-432 was administered intratumorally via a tube to 4 malignant glioma patients on Days 1, 3, 5, 7 and 12 in doses of 0.5 KE, 1 KE, 2 KE, and 3 KE, respectively. Cerebrospinal fluid (CSF) was collected several times during the 24-hour period beginning immediately after the administration on Day 12. The CSF was added to the culture medium of rat glioma cells (GA-1 and C-6) in order to observe the cytotoxic effect morphologically. The clinical efficacy in the patients was evaluated from the changes in tumor size observed by CT. CSF collected from the tumor cavity of 3 patients was bloody. By adding this bloody CSF, a significant morphological cytotoxic effect was observed on both the GA-1 and C-6 glioma cells in culture. The level of cytotoxicity was higher with the bloody fluid collected at 4 to 24 hours after the final administration than with the bloody fluid collected immediately after the final administration. The cytotoxic effect of this fluid was stronger than that of rabbit TNF (tumor necrosis factor) serum induced with P. acnes and LPS.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Brain Neoplasms/therapy , Glioma/therapy , Picibanil/administration & dosage , Animals , Brain Neoplasms/pathology , Glioma/pathology , Humans , Injections, Intralesional , Picibanil/therapeutic use , Rabbits , Rats
9.
No Shinkei Geka ; 18(1): 39-45, 1990 Jan.
Article in Japanese | MEDLINE | ID: mdl-2304608

ABSTRACT

UNLABELLED: We have already reported that DCS (Dorsum Column Stimulation) alleviates the clinical symptoms of patients in vegetative status. Since then, we have accumulated information about 23 cases that have been treated by DCS therapy. In this paper, we describe the clinical outcome and compare cases where the treatment was effective with those where it was non-effective to evaluate the indications for further use of this treatment. RESULTS: 1) Eight of these cases showed good clinical improvement. 2) Most of the cases where the treatment was effective were young. Starting neurostimulation early brought about better clinical effects. 3) The clinical effects appeared 1-12 months after the start of the neurostimulation. 4) CT findings in the cases which had been treated effectively showed no marked cerebral atrophy, and no bilateral large diffuse low-density areas not involving the thalamus. Neither did they show any definite and large low-density areas in the brainstem. In conclusion, when the dorsum column was stimulated to treat vegetative status in which CT disclosed none of the abnormal findings described above, it increased r-CBF, enhanced the metabolism of catecholamine, and brought clinical improvement.


Subject(s)
Coma/therapy , Electric Stimulation Therapy/methods , Adolescent , Adult , Aged , Child, Preschool , Female , Humans , Male , Middle Aged , Spinal Cord/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL
...